Innate Pharma and MedImmune will test the combination of Innate’s cancer antibody and the checkpoint inhibitor durvalumab in patients with solid tumors.
{iframe}https://labiotech.eu/cancer-antibodies-innate-medimmune/{/iframe}
About BioHealth Innovation
BioHealth Innovation, Inc. (BHI) is an innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets.
Connect
© 2025 BioHealth Innovation.